BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32787581)

  • 1. Circular RNA hsa_Circ_101141 as a Competing Endogenous RNA Facilitates Tumorigenesis of Hepatocellular Carcinoma by Regulating miR-1297/ROCK1 Pathway.
    Zhang T; Zhang L; Han D; Tursun K; Lu X
    Cell Transplant; 2020; 29():963689720948016. PubMed ID: 32787581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression.
    Nie Y; Zhu X; Bu N; Jiang Y; Su Y; Pan K; Li S
    BMC Cancer; 2022 Mar; 22(1):265. PubMed ID: 35287604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.
    Sun R; Li H; Li J; Shen S; Cui G; Dong G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0009910 promotes proliferation and metastasis of hepatocellular carcinoma cells through miR-335-5p/ROCK1 axis.
    Li HW; Liu J
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1725-1735. PubMed ID: 32141540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
    Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
    Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Mao Y
    Aging (Albany NY); 2020 May; 12(10):9793-9806. PubMed ID: 32464601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase.
    Chen M; Hu G; Zhou X; Peng Z; Wen W
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
    Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
    J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.